ArticleScientific reports2022

Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway.

Olfa Khalifa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.